ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

United States Drug Testing Laboratories, INC

Official 2024 U.S. DOL Form 5500 summary for United States Drug Testing Laboratories, INC (United States Drug Testing 401(k) Profit Sharing Plan And Trust · EIN 42-1612910 · PN 001): $10.26M net assets, 136 active participants, and $37.99 per $10,000 (37.99 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorUnited States Drug Testing Laboratories, INC
Filing IdentifierUnited States Drug Testing 401(k) Profit Sharing Plan And Trust · EIN 42-1612910 · PN 001
Plan Category & State401(k) Defined Contribution (IL)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$10.26M
Active Participants136
Direct Admin Fee Rate$37.99 per $10,000 (37.99 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI